Your browser doesn't support javascript.
loading
Tildrakizumab: interpreting the data.
Purvis, C G; Emmerich, V K; Feldman, S R.
Affiliation
  • Purvis CG; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Emmerich VK; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Feldman SR; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Br J Dermatol ; 185(2): 242-243, 2021 08.
Article in En | MEDLINE | ID: mdl-34031870
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Antibodies, Monoclonal, Humanized Limits: Humans Language: En Journal: Br J Dermatol Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Antibodies, Monoclonal, Humanized Limits: Humans Language: En Journal: Br J Dermatol Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido